Cost-effectiveness analysis of acute heart failure treatmentResearch Project | 01.10.2013 - 31.12.2017 Cost-effectiveness analysis of serelaxin in the treatment of acute heart failureFundingCost-effectiveness analysis of acute heart failure treatmentIndustriegelder, Sonstige Forschungskooperationen (GrantsTool), 10.2013-12.2014 (15) PI : Schwenkglenks, Matthias.CI : Szucs, Thomas.Members (2) Matthias SchwenkglenksPrincipal Investigator Thomas SzucsCo-InvestigatorResearch Groups European Center of Pharmaceutical Medicine (ECPM) Pharmazeutische Medizin (Szucs)
Cost-effectiveness analysis of acute heart failure treatmentResearch Project | 01.10.2013 - 31.12.2017
FundingCost-effectiveness analysis of acute heart failure treatmentIndustriegelder, Sonstige Forschungskooperationen (GrantsTool), 10.2013-12.2014 (15) PI : Schwenkglenks, Matthias.CI : Szucs, Thomas.
Cost-effectiveness analysis of acute heart failure treatmentIndustriegelder, Sonstige Forschungskooperationen (GrantsTool), 10.2013-12.2014 (15) PI : Schwenkglenks, Matthias.CI : Szucs, Thomas.